The joint clinical research office builds on the work the organizations have done over the last seven months to collaboratively launch about 35 COVID-19 clinical trials, several of which are part of larger national clinical trials. Including the COVID-19 trials, Tampa General and USF Health are working together on about 350 research studies.
“We already have established and invested in a strong foundation for clinical research,” Tampa General President and CEO John Couris said in a news release. “Combining the efforts of TGH and USF Health is the next step to elevate the world-class research we do to push forward to the edge of scientific discovery.”
More articles on healthcare industry transactions:
Steward acquires 3 hospitals in Colombia
Washington hospital unwinds from Virginia Mason
Merger would create 4-hospital system in Southern Illinois
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.